|
|
1339: Neoantigen-specific T-cell receptors targeting recurrent mutations in AML |
|
22 January |
10:00
10:15
|
SC Papendal
Room 15
|
|
|
|
1419: In silico and in vitro approaches identify SNX.2112 as a t(7;12) AML drug vulnerability... |
|
22 January |
10:15
10:30
|
SC Papendal
Room 15
|
|
|
|
1421: Understanding relapse mechanisms post allogenic transplantation |
|
22 January |
10:30
10:45
|
SC Papendal
Room 15
|
|
|
|
1435: lenalidomide response in lower risk myelodysplastic neoplasms |
|
22 January |
10:45
11:00
|
SC Papendal
Room 15
|
|
